{{Other uses|subject=一種細菌及疾病|other=地质学中的同名名詞|结核 (地质学)}}
{{medical}}
{{Infobox medical condition
| name = 结核病
| image = Tuberculosis-x-ray-1.jpg
| caption = 嚴重結核病患者的胸部[[X射线|X光]]：病灶位於白色箭頭之中，其中包圍的黑色部分為空腔。
| field = {{tsl|en|Infectious disease (medical specialty)|感染科}}、[[胸腔醫學|胸腔醫學]]、[[傳染病|傳染病]]
| synonyms = Phthisis, phthisis pulmonalis, consumption
| symptoms = 慢性咳嗽、[[發燒|發燒]]、[[咳血|咳血]]、[[體重下降|體重下降]]<ref name=WHO2015Fact/>
| onset = 
| duration = 
| causes = [[結核桿菌|結核桿菌]] ''Mycobacterium tuberculosis''<ref name=WHO2015Fact/>
| risks = 吸菸、[[艾滋病|艾滋病]]<ref name=WHO2015Fact/>
| diagnosis = [[胸部X光|胸部X光]]、{{tsl|en|microbial culture|細菌培養}}、[[结核菌素试验|结核菌素试验]]<ref name=WHO2015Fact/>
| differential = [[肺炎|肺炎]]、[[組織胞漿菌病|組織胞漿菌病]]、[[结节病|结节病]]、{{tsl|en|coccidioidomycosis|粗球孢子菌症}}<ref>{{cite book|last1=Ferri|first1=Fred F.|title=Ferri's differential diagnosis : a practical guide to the differential diagnosis of symptoms, signs, and clinical disorders|date=2010|publisher=Elsevier/Mosby|location=Philadelphia, PA|isbn=0323076998|page=Chapter T|edition=2nd}}</ref>
| prevention = 
| treatment = [[抗细菌药|抗细菌药]]<ref name=WHO2015Fact/>
| medication = 
| frequency = 33%的人<ref name=WHO2015Fact/>
| deaths = 130萬人（2016年）<ref name=WHO2017Report>{{Cite web|url=http://www.who.int/tb/publications/global_report/en/|title=Global tuberculosis report|website=World Health Organization|language=en-GB|access-date=2017-11-09|archive-date=2017-10-30|archive-url=https://web.archive.org/web/20171030205301/http://www.who.int/tb/publications/global_report/en/|dead-url=no}}</ref>
}}
<!-- Definition and symptoms -->
'''结核病'''（{{lang|en|Tuberculosis}}，又稱'''TB'''）為[[結核桿菌|結核桿菌]]感染引起的疾病。结核通常造成[[肺|肺]]部感染，也会感染身体的其他部分<ref name=WHO2015Fact/>。大多數感染者沒有症狀，此型態感染稱為{{le|潛伏結核感染|Latent tuberculosis}}。如果此時沒有適當治療，10%的潛伏感染患者會惡化為開放性結核病（Active tuberculosis），致死率為 50%。結核病的典型症狀包含慢性[[咳嗽|咳嗽]]、[[咳血|咳血]]、[[發燒|發燒]]、夜間[[潮熱|潮熱]]，以及[[減肥|體重減輕]]<ref name=Cha1998>{{cite book|title=The Chambers Dictionary.|year=1998|publisher=Allied Chambers India Ltd.|location=New Delhi|isbn=978-81-86062-25-8|pages=352|url=https://books.google.com/books?id=pz2ORay2HWoC&pg=RA1-PA352}}</ref>。感染其他器官則可能導致其他症狀。<ref name=ID10>{{cite book|last=Dolin|first=[edited by] Gerald L. Mandell, John E. Bennett, Raphael|title=Mandell, Douglas, and Bennett's principles and practice of infectious diseases|year=2010|publisher=Churchill Livingstone/Elsevier|location=Philadelphia, PA|isbn=978-0-443-06839-3|pages=Chapter 250|edition=7th}}</ref>

結核病屬於[[空氣傳播疾病|空氣傳播疾病]]。意即病原體會藉由開放性結核患者咳嗽、打噴嚏，或說話過程中所產生的飛沫散佈<ref name=WHO2015Fact/><ref name=CDC2012B>{{cite web|title=Basic TB Facts|url=http://www.cdc.gov/tb/topic/basics/default.htm|website=CDC|accessdate=2016-02-11|date=2012-03-13|archive-date=2016-02-06|archive-url=https://web.archive.org/web/20160206032136/http://www.cdc.gov/tb/topic/basics/default.htm|dead-url=no}}</ref>；而潛伏性結核病患者則不會散布疾病。開放性結核常發生於[[鼠疫|鼠疫]]及[[愛滋病|愛滋病]]患者<ref name=WHO2015Fact/>，需藉由[[胸部X光|胸部X光]]、[[顯微鏡|顯微鏡檢]]，及體液培養來進行診斷。潛伏性結核病患者則可利用[[結核菌素試驗|結核菌素試驗]]或血液檢查來診斷。<ref>{{Cite journal|title=Diagnostic tests: Testing for tuberculosis|url=https://www.nps.org.au/australian-prescriber/magazine/33/1/12/18|last=Konstantinos|first=Anastasios|date=2010-02-01|journal=Australian Prescriber|issue=1|doi=10.18773/austprescr.2010.005|volume=33|pages=12–18}}</ref>

預防肺結核可透過篩檢高風險者、早期診斷和治療，以及接種[[卡介苗|卡介苗]]等方法達成<ref>{{Cite journal|title=Tuberculosis Vaccines and Prevention of Infection|url=https://journals.asm.org/doi/10.1128/MMBR.00021-14|last=Hawn|first=Thomas R.|last2=Day|first2=Tracey A.|date=2014-12|journal=Microbiology and Molecular Biology Reviews|issue=4|doi=10.1128/MMBR.00021-14|volume=78|pages=650–671|language=en|issn=1092-2172|pmc=PMC4248657|pmid=25428938|last3=Scriba|first3=Thomas J.|last4=Hatherill|first4=Mark|last5=Hanekom|first5=Willem A.|last6=Evans|first6=Thomas G.|last7=Churchyard|first7=Gavin J.|last8=Kublin|first8=James G.|last9=Bekker|first9=Linda-Gail}}</ref><ref>{{cite book|last1=Harris|first1=Randall E.|title=Epidemiology of chronic disease: global perspectives|url=https://archive.org/details/epidemiologyofch0000harr|date=2013|publisher=Jones & Bartlett Learning|location=Burlington, MA|isbn=9780763780470|page=[https://archive.org/details/epidemiologyofch0000harr/page/682 682]|ref=https://books.google.ca/books?id=KJLEIvX4wzoC&pg=PA682}}</ref><ref name=TBCon2008>{{cite book|last1=Organization|first1=World Health|title=Implementing the WHO Stop TB Strategy: a handbook for national TB control programmes|date=2008|publisher=World Health Organization|location=Geneva|isbn=9789241546676|page=179|url=https://books.google.ca/books?id=EUZXFCrlUaEC&pg=PA179|access-date=2016-09-05|archive-date=2016-02-16|archive-url=https://web.archive.org/web/20160216180345/https://books.google.ca/books?id=EUZXFCrlUaEC&pg=PA179|dead-url=no}}</ref>。高風險者包含生活環境中與開放性結核病患者密切接觸的人<ref name=TBCon2008/>。治療通常搭配不同的[[抗细菌药|抗生素]]組合做一段時間的治療。近年帶有[[抗生素抗藥性|抗生素抗藥性]]的結核桿菌（MDR-TB）日益增加。<ref name=WHO2015Fact/>

世界上大約有三分之一的人口患有無法傳染的潛伏性結核病<ref name=WHO2015Fact/>。全球每年大約有1%的人口新感染該病<ref name=WHO2002>{{cite web|title=Tuberculosis|url=http://www.who.int/mediacentre/factsheets/who104/en/print.html|work=World Health Organization|year=2002|deadurl=yes|archiveurl=https://web.archive.org/web/20130617193438/http://www.who.int/mediacentre/factsheets/who104/en/print.html|archivedate=2013-06-17}}</ref>，2014年全球有960萬名開放性結核病患者，150萬例死亡，死亡者當中有95%是來自[[發展中國家|發展中國家]]。自2000年起，全球新病例數已逐年下降<ref name=WHO2015Fact>{{cite web|title=Tuberculosis Fact sheet N°104|url=http://www.who.int/mediacentre/factsheets/fs104/en/|website=WHO|accessdate=2016-02-11|date=October 2015|archive-date=2012-08-23|archive-url=https://web.archive.org/web/20120823143802/http://www.who.int/mediacentre/factsheets/fs104/en/|dead-url=no}}</ref>。在許多[[亚洲|亞洲]]與[[非洲|非洲]]國家，大約有80%的人肺結核檢驗結果為陽性，而在[[美國|美國]]的人口中約有5-10%的人肺結核檢驗為陽性<ref name=Robbins>{{cite book |vauthors=Kumar V, Abbas AK, Fausto N, Mitchell RN |year=2007 |title=Robbins Basic Pathology |url=https://archive.org/details/robbinsbasicpath0000unse_q0t1 |edition=8th |publisher=Saunders Elsevier |pages=[https://archive.org/details/robbinsbasicpath0000unse_q0t1/page/516 516]–522 |isbn=978-1-4160-2973-1}}</ref>。結核病在[[古代史|古代史]]中就有記載。<ref name=Lancet11>{{cite journal|last=Lawn|first=SD|author2=Zumla, AI |title=Tuberculosis|journal=Lancet|date=2011-07-02|volume=378|issue=9785|pages=57–72|pmid=21420161|doi=10.1016/S0140-6736(10)62173-3}}</ref>

结核病也是一种人兽共患的传染病，可以感染包括[[人|人]]在内的不同种属的[[温血动物|温血动物]]，包括[[有蹄类|有蹄类]]、[[食肉目|食肉类]]和[[啮齿动物|啮齿动物]]等<ref>{{Cite journal|title=Problems and countermeasures in the surveillance and research of wildlife epidemics based on mammals in China|url=https://www.biodiversity-science.net/EN/10.17520/biods.2020124|last=Xiao|first=Zhishu|last2=Zhang|first2=Libiao|date=2020-05-20|journal=Biodiversity Science|issue=5|doi=10.17520/biods.2020124|volume=28|pages=566|language=en|issn=1005-0094|last3=Xu|first3=Lei|last4=Zhou|first4=Qihai|last5=Meng|first5=Xiuxiang|last6=Yan|first6=Chuan|last7=Chang|first7=Gang}}</ref>。

==臨床體徵與症狀==
[[File:Tuberculosis_symptoms.svg|thumb]]Health|author=Schiffman G|date=2009-01-15|accessdate=2016-11-21|archive-date=2009-05-16|archive-url=https://web.archive.org/web/20090516075020/http://www.emedicinehealth.com/tuberculosis/page3_em.htm|dead-url=no}}</ref>。許多變種的主要症狀相互重疊，而又有一些變種有其獨特（但並不一定是完全獨特）的症狀，幾個變種的症狀也可同時表現出來。]]
結核病可以在全身的任何一個部位發病，但最常發病於肺（即被稱為肺結核）。肺外結核病（即在肺以外的器官發生的結核病）可能與肺結核共同存在<ref name=ID10/>。

結核病一般的臨床體徵與症狀包括[[發熱|發熱]]、[[發冷|發冷]]、[[盜汗|盜汗]]、[[食慾不振|食慾不振]]、[[減肥|體重減輕]]以及[[疲倦|疲倦]]<ref name="ID10" />。結核病患者也可能出現明顯的{{le|杵狀指甲|Nail clubbing}}症狀<ref name="Pet2005">{{cite book|last1=Gibson|title=Evidence-Based Respiratory Medicine|archive-url=https://web.archive.org/web/20151208072842/http://www.wiley.com/WileyCDA/WileyTitle/productCd-072791605X.html|archive-date=2015-12-08|access-date=2016-11-26|url=http://www.wiley.com/WileyCDA/WileyTitle/productCd-072791605X.html|edition=1st|page=321|isbn=978-0-7279-1605-1|publisher=BMJ Books|date=2005|first6=Ulrich (ed.)|first1=Peter G. (ed.)|last6=Costabel|first5=Michael (ed.)|last5=Hensley|first4=Jimmy (ed.)|last4=Volmink|first3=Richard (ed.)|last3=Wood-Baker|first2=Michael (ed.)|last2=Abramson|dead-url=no}}</ref>。

===肺結核===
開放性結核病最常見於肺部（占約90%的病例）<ref name=Lancet11/><ref>{{cite book|last=Behera|first=D.|title=Textbook of Pulmonary Medicine|year=2010|publisher=Jaypee Brothers Medical Publishers|location=New Delhi|isbn=978-81-8448-749-7|pages=457|url=https://books.google.com/books?id=0TbJjd9eTp0C&pg=PA457|edition=2nd}}</ref>。肺結核的症狀可能包含[[胸痛|胸痛]]和長時間帶痰咳嗽，而約有25%的人可能不會表現任何症狀（即「無症狀的」）<ref name=Lancet11/>。 偶爾，患者可能小量的[[咳血|咳血]]、[[咳嗽|咳嗽]]，在極為罕見的病例中，感染可能侵蝕到[[肺動脈|肺動脈]]和{{le|雷斯莫森氏動脈瘤|Rasmussen's aneurysm}}，導致大量出血<ref name=ID10/><ref>{{cite journal|last1=Halezeroğlu|first1=S|last2=Okur|first2=E|title=Thoracic surgery for haemoptysis in the context of tuberculosis: what is the best management approach?|journal=Journal of Thoracic Disease|date=March 2014|volume=6|issue=3|pages=182–5|pmid=24624281|doi=10.3978/j.issn.2072-1439.2013.12.25}}</ref>。肺結核可能演變成慢性疾病，並導致上肺葉產生大疤痕。上肺葉比下肺葉更易受到肺結核的影響<ref name=ID10/>，但這個差別的原因目前還未明。可能的解釋為上肺葉的空氣流通較佳<ref name="Robbins" />，或其[[淋巴|淋巴]]引流能力較差<ref name=ID10/>。

===肺外結核病===
在15％至20%的開放性結核病案例中，結核桿菌感染可傳播至肺外，引起其他種類的結核病<ref>{{cite book|last=Jindal|first=editor-in-chief SK|title=Textbook of Pulmonary and Critical Care Medicine|publisher=Jaypee Brothers Medical Publishers|location=New Delhi|isbn=978-93-5025-073-0|pages=549|url=https://books.google.com/books?id=EvGTw3wn-zEC&pg=PA549|year=2011}}</ref>。這些病症被歸類為「肺外結核病」。 肺外結核病常發生於存在[[免疫抑制|免疫抑制]]的個體或幼兒，50％以上患有肺結核的HIV病毒攜帶者均患有肺外結核病<ref>{{Cite journal|title=Extrapulmonary tuberculosis: an overview|url=https://pubmed.ncbi.nlm.nih.gov/16300038|last=Golden|first=Marjorie P.|last2=Vikram|first2=Holenarasipur R.|date=2005-11-01|journal=American Family Physician|issue=9|volume=72|pages=1761–1768|issn=0002-838X|pmid=16300038}}</ref>。肺外結核病常發病於[[胸膜腔|胸膜腔]]（結核性胸膜炎）、[[中樞神經系統|中樞神經系統]]（結核性[[腦膜炎|腦膜炎]]）、[[淋巴系統|淋巴系統]]（即頸部{{le|淋巴結核|Scofula}}，又稱瘰癧）、泌尿生殖道系統（即{{le|尿殖道結核|urogenital tuberculosis}}），以及骨與筋腱（即[[博特氏病|博特氏病]]；脊柱結核性彎曲）等部位。當結核病發病於骨骼時，也被稱為「骨結核病」<ref>{{cite book|last=Kabra|first=[edited by] Vimlesh Seth, S.K.|title=Essentials of tuberculosis in children|year=2006|publisher=Jaypee Bros. Medical Publishers|location=New Delhi|isbn=978-81-8061-709-6|pages=249|url=https://books.google.com/books?id=HkH0YbyBHDQC&pg=PA249|edition=3rd}}</ref>，即一種骨髓炎<ref name="Robbins" />。有時結核性膿腫破出皮膚導致結核性潰瘍<ref>{{cite book|title=Manual of Surgery|url=https://archive.org/details/manualofsurgery0000thom|year=2008|publisher=Kaplan Publishing|isbn=9781427797995|pages=[https://archive.org/details/manualofsurgery0000thom/page/75 75]}}</ref>。由周圍感染的淋巴結產生的潰瘍常表現為無痛、緩慢擴大以及看起來像水洗過的皮革的特性<ref>{{cite book|last=Burkitt|first=H. George|title=Essential Surgery: Problems, Diagnosis & Management 4th ed|year=2007|isbn=9780443103452|pages=34}}</ref>。彌散性結核病是一種更具危險性、更易擴散的結核病，也被稱為{{le|粟粒狀結核|Milliary tuberculosis}}<ref name=ID10/>，粟粒狀結核占肺外結核病例的10％<ref name=Gho2008>{{cite book|last=Ghosh|first=editors-in-chief, Thomas M. Habermann, Amit K.|title=Mayo Clinic internal medicine: concise textbook|year=2008|publisher=Mayo Clinic Scientific Press|location=Rochester, MN|isbn=978-1-4200-6749-1|pages=789|url=https://books.google.com/books?id=YJtodBwNxokC&pg=PA789}}</ref>。

另外在台灣較常見的肺外結核為淋巴結核和骨結核，而結核性腦膜炎為其次，肺外結核的發生率比肺結核低<ref>{{Cite web|url=http://www.cdc.gov.tw/professional/knowdisease.aspx?treeid=beac9c103df952c4&nowtreeid=89b930c89c1c71cf&id=FE81C4ADE2A4A38F&did=652|title=台灣衛生福利部疾病管制署-傳染病介紹-肺結核|accessdate=2016年9月12日|author=|date=|publisher=|archive-url=https://web.archive.org/web/20161121234430/http://www.cdc.gov.tw/professional/knowdisease.aspx?treeid=beac9c103df952c4&nowtreeid=89b930c89c1c71cf&id=FE81C4ADE2A4A38F&did=652|archive-date=2016年11月21日|dead-url=yes}}</ref>。而在中国大陆，以1996年至1999年上海市的流行病學研究為例，肺外结核發病案例以周围淋巴结结核为主,占38.3%,余依次为骨关节结核(19.9%)、泌尿生殖系统结核(16.7%)及肠、腹膜结核(9.1%)和脑神经结核(6.4%)。男女之比为1:1.35<ref>{{Cite web |url=http://xueshu.baidu.com/s?wd=paperuri:(d147935dcd632838cebe56fdcadb8a1d)&filter=sc_long_sign&tn=SE_xueshusource_2kduw22v&sc_vurl=http://wenku.baidu.com/view/b4863f8b3186bceb19e8bba4.html&ie=utf-8&sc_us=6562174529045101614 |title=上海市肺外结核的流行病学分析|accessdate=2016-11-21|work=xueshu.baidu.com}}</ref>。

==病因==
===分枝桿菌屬===
{{main|結核桿菌}}
[[File:Mycobacterium_tuberculosis.jpg|thumb]]下的結核桿菌]]
[[結核桿菌|結核桿菌]]是主要引起結核病的致病原，它是一個小型、[[好氧生物|好氧]]、不具活動性的細菌，屬於[[分枝桿菌屬|分枝桿菌屬]]<ref name=ID10/>。結核桿菌的生長速度與其他細菌相比非常緩慢，細胞每16至20小時才[[分裂_(生物学)|分裂]]一次，而其他細菌一般則不到半小時即分裂一次<ref>{{cite book|last=Jindal|first=editor-in-chief SK|title=Textbook of Pulmonary and Critical Care Medicine|publisher=Jaypee Brothers Medical Publishers|location=New Delhi|isbn=978-93-5025-073-0|pages=525|url=https://books.google.com/books?id=rAT1bdnDakAC&pg=PA525|year=2011}}</ref>。結核桿菌還有一個特殊的雙層脂質[[細菌結構|外膜]]<ref name=Niederweis2010>{{cite journal |vauthors=Niederweis M, Danilchanka O, Huff J, Hoffmann C, Engelhardt H |title=Mycobacterial outer membranes: in search of proteins |journal=Trends in Microbiology |volume=18 |issue=3 |pages=109–16 |date=March 2010 |pmid=20060722 |pmc=2931330 |doi=10.1016/j.tim.2009.12.005 }}</ref>。細胞壁富含脂質是分枝桿菌屬特有的臨床特徵<ref>{{cite book |author=Southwick F |title=Infectious Diseases: A Clinical Short Course, 2nd ed. |publisher=McGraw-Hill Medical Publishing Division |date=2007-12-10 |pages=104, 313–4 |chapter=Chapter 4: Pulmonary Infections |isbn=0-07-147722-5}}</ref>，使用一般的[[革蘭氏染色|革蘭氏染色]]鑑定，會出現不明顯的陽性反應或無法被染上色的現象，原因就是其細胞壁中富含脂質以及{{le|黴菌酸（分枝菌酸）|Mycolic acid}}（一種脂肪酸）<ref name=Madison_2001>{{cite journal |author=Madison B |title=Application of stains in clinical microbiology |journal=Biotechnic & Histochemistry |volume=76 |issue=3 |pages=119–25 |year=2001 |pmid=11475314 |doi=10.1080/714028138}}</ref>。在自然界，結核桿菌只能生長於[[宿主|宿主]]個體的細胞中，但在實驗室中可[[In_vitro|在試管內]]培養<ref name=Parish_1999>{{cite journal |author1=Parish T. |author2=Stoker N. |title=Mycobacteria: bugs and bugbears (two steps forward and one step back) |journal=Molecular Biotechnology |volume=13 |issue=3 |pages=191–200 |year=1999| pmid=10934532 |doi = 10.1385/MB:13:3:191}}</ref>。

醫檢師可利用[[组织_(生物学)|組織]]染色法處理[[痰液|痰液]]檢體，便可用顯微鏡鑑別出結核桿菌。因為結核桿菌染色後不會被酸性溶劑沖洗掉，分類上又被稱為{{link-en|抗酸性桿菌|Acid-fast bacillus}}<ref name="Robbins" /><ref name="Madison_2001" />。目前最常用的耐酸染色法是[[齐尔-尼尔森染色|齐尔-尼尔森染色]]及{{link-en|金氏（Kinyoun）染色|Kinyoun stain}}，兩染色法在顯微鏡下所見的背景為藍色，而結核桿菌則是呈現紅色<ref name="Stain2000">{{cite book |title=Medical Laboratory Science: Theory and Practice |publisher=Tata McGraw-Hill |location=New Delhi |year=2000 |pages=473 |isbn=0-07-463223-X |url=https://books.google.com/books?id=lciNs3VQPLoC&pg=PA473}}</ref><ref>{{cite web|title=Acid-Fast Stain Protocols|url=http://www.microbelibrary.org/component/resource/laboratory-test/2870-acid-fast-stain-protocols|accessdate=2016-03-26|date=2013-08-21|deadurl=yes|archiveurl=https://web.archive.org/web/20111001132818/http://www.microbelibrary.org/component/resource/laboratory-test/2870-acid-fast-stain-protocols|archivedate=2011年10月1日}}</ref>。另外也可使用{{link-en|金胺-若丹明（Auramine-rhodamine ）染色法|Auramine-rhodamine stain}}，並在[[螢光顯微鏡|螢光顯微鏡]]下觀察<ref name="Kommareddi_1984">{{cite journal|author1=Kommareddi S. |author2=Abramowsky C. |author3=Swinehart G. |author4=Hrabak L. |title=Nontuberculous mycobacterial infections: comparison of the fluorescent auramine-O and Ziehl-Neelsen techniques in tissue diagnosis|url=https://archive.org/details/sim_human-pathology_1984-11_15_11/page/1085 |journal=Human Pathology|volume=15|issue=11|pages=1085–1089|year=1984|pmid=6208117|doi=10.1016/S0046-8177(84)80253-1}}</ref><ref>{{cite book|last1=van Lettow|first1=Monique|last2=Whalen|first2=Christopher|title=Nutrition and health in developing countries|year=2008|publisher=Humana Press|location=Totowa, N.J. (Richard D. Semba and Martin W. Bloem, eds.)|isbn=978-1-934115-24-4|pages=291|url=https://books.google.com/books?id=RhH6uSQy7a4C&pg=PA291|edition=2nd}}</ref>。

结核分枝杆菌复合群(MTBC)包括其他四种可引起结核病的[[分枝桿菌屬|分枝桿菌屬]]的細菌：{{le|牛分枝桿菌|Mycobacterium bovis}}、{{le|非洲分枝桿菌|Mycobacterium africanum}}、{{le|卡氏分枝桿菌|Mycobacterium canetti}}及{{le|田鼠分枝桿菌|Mycobacterium microti}}<ref>{{cite journal |author=van Soolingen D. |title=A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa |journal=International Journal of Systematic Bacteriology |volume=47 |issue=4 |pages=1236–45 |year=1997 |pmid=9336935 |doi=10.1099/00207713-47-4-1236 |name-list-format=vanc |display-authors=1 |last2=Hoogenboezem |first2=T. |last3=De Haas |first3=P.E.W.|last4=Hermans |first4=P.W.M. |last5=Koedam |first5=M.A. |last6=Teppema |first6=K.S. |last7=Brennan |first7=P.J.|last8=Besra |first8=G.S.|last9=Portaels |first9=F.}}</ref>。 非洲分枝桿菌分佈不廣，但卻是導致非洲結核病感染的重要因素<ref>{{Cite journal|title=Mycobacterium africanum Subtype II Is Associated with Two Distinct Genotypes and Is a Major Cause of Human Tuberculosis in Kampala, Uganda|url=https://journals.asm.org/doi/10.1128/JCM.40.9.3398-3405.2002|last=Niemann|first=S.|last2=Rüsch-Gerdes|first2=S.|date=2002-09|journal=Journal of Clinical Microbiology|issue=9|doi=10.1128/JCM.40.9.3398-3405.2002|volume=40|pages=3398–3405|language=en|issn=0095-1137|pmc=PMC130701|pmid=12202584|last3=Joloba|first3=M. L.|last4=Whalen|first4=C. C.|last5=Guwatudde|first5=D.|last6=Ellner|first6=J. J.|last7=Eisenach|first7=K.|last8=Fumokong|first8=N.|last9=Johnson|first9=J. L.}}</ref><ref>{{Cite journal|title=Genetic Biodiversity of Mycobacterium tuberculosis Complex Strains from Patients with Pulmonary Tuberculosis in Cameroon|url=https://journals.asm.org/doi/10.1128/JCM.41.6.2547-2553.2003|last=Niobe-Eyangoh|first=Sara Ngo|last2=Kuaban|first2=Christopher|date=2003-06|journal=Journal of Clinical Microbiology|issue=6|doi=10.1128/JCM.41.6.2547-2553.2003|volume=41|pages=2547–2553|language=en|issn=0095-1137|pmc=PMC156567|pmid=12791879|last3=Sorlin|first3=Philippe|last4=Cunin|first4=Patrick|last5=Thonnon|first5=Jocelyn|last6=Sola|first6=Christophe|last7=Rastogi|first7=Nalin|last8=Vincent|first8=Veronique|last9=Gutierrez|first9=M. Cristina}}</ref>。牛分枝桿菌曾是導致結核病感染的常見因素，但因[[巴斯德消毒法|巴式消毒法]]在牛奶生產中的使用，在發達國家已幾乎不再出現牛分枝桿菌導致結核病感染的病例<ref name="Robbins" /><ref>{{cite journal |vauthors=Thoen C, Lobue P, de Kantor I |title=The importance of ''Mycobacterium bovis'' as a zoonosis |journal=Veterinary Microbiology |volume=112 |issue=2–4 |pages=339–45 |year=2006 |pmid=16387455 |doi=10.1016/j.vetmic.2005.11.047}}</ref>。卡式分枝桿菌較為罕見，且似乎僅出現於[[非洲之角|非洲之角（東北非洲）]]，但也有少數幾例病例出現於非洲裔移民中<ref>{{cite book|last=Acton|first=Q. Ashton|title=Mycobacterium Infections: New Insights for the Healthcare Professional|year=2011|publisher=ScholarlyEditions|isbn=978-1-4649-0122-5|pages=1968|url=https://books.google.com/books?id=g2iFfV6uEuAC&pg=PA1968}}</ref><ref>{{Cite journal|title=Mycobacterium canettii, the smooth variant of M. tuberculosis, isolated from a Swiss patient exposed in Africa|url=https://pubmed.ncbi.nlm.nih.gov/9866740|last=Pfyffer|first=G. E.|last2=Auckenthaler|first2=R.|date=1998-10|journal=Emerging Infectious Diseases|issue=4|doi=10.3201/eid0404.980414|volume=4|pages=631–634|issn=1080-6040|pmc=2640258|pmid=9866740|last3=van Embden|first3=J. D.|last4=van Soolingen|first4=D.}}</ref>。田鼠分枝桿菌也較為罕見，且幾乎僅出現於免疫不全人群，但其[[盛行率|盛行率]]可能被嚴重低估<ref>{{cite journal|last=Panteix|first=G|author2=Gutierrez, MC |author3=Boschiroli, ML |author4=Rouviere, M |author5=Plaidy, A |author6=Pressac, D |author7=Porcheret, H |author8=Chyderiotis, G |author9=Ponsada, M |author10=Van Oortegem, K |author11=Salloum, S |author12=Cabuzel, S |author13=Bañuls, AL |author14=Van de Perre, P |author15=Godreuil, S |title=Pulmonary tuberculosis due to Mycobacterium microti: a study of six recent cases in France|journal=Journal of Medical Microbiology|date=August 2010|volume=59|issue=Pt 8|pages=984–9|pmid=20488936|doi=10.1099/jmm.0.019372-0}}</ref>

其他致病分枝桿菌屬細菌包括[[痲瘋桿菌|痲瘋桿菌]]、{{link-en|鳥分枝桿菌|Mycobacterium avium complex}}及{{link-en|堪塞斯分枝桿菌|Mycobacterium kansasii}}。後兩者被歸為{{link-en|非结核性分枝杆菌(NTM)|Nontuberculous mycobacteria}}。非结核性分枝杆菌既不能引起結核病也不能引起[[痲瘋病|痲瘋病]]，但其感染會導致相似於結核病的肺部疾病<ref name="ALA_1997">{{cite journal |title=Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association |journal=American Journal of Respiratory and Critical Care Medicine |volume=156 |issue=2 Pt 2 |pages=S1–25 |year=1997 |pmid = 9279284 |author=American Thoracic Society |doi=10.1164/ajrccm.156.2.atsstatement }}</ref>。

===危險因子===
有許多因子會讓人更容易罹患肺結核。目前全球最重要的一項危險因子是[[HIV|HIV]]病毒；在罹患肺結核的病人中，有13%是HIV病毒感染的患者<ref name=WHO2011>{{cite web|title=The sixteenth global report on tuberculosis|author=World Health Organization|url=http://www.who.int/tb/publications/global_report/2011/gtbr11_executive_summary.pdf|year=2011|deadurl=yes|archiveurl=https://web.archive.org/web/20120906223650/http://www.who.int/tb/publications/global_report/2011/gtbr11_executive_summary.pdf|archivedate=2012-09-06}}</ref>。 該問題在[[撒哈拉以南非洲|漠南非洲]]尤其顯著，因為這個區域愛滋病罹患率相當高<ref>{{cite web|author=World Health Organization|url=http://www.who.int/tb/publications/global_report/en/index.html|title=Global tuberculosis control–surveillance, planning, financing WHO Report 2006|accessdate=2006-10-13|archive-date=2006-12-12|archive-url=https://web.archive.org/web/20061212123736/http://www.who.int/tb/publications/global_report/en/index.html|dead-url=no}}</ref><ref name=":2">{{cite journal|last=Chaisson|first=RE|author2=Martinson, NA |title=Tuberculosis in Africa—combating an HIV-driven crisis|journal=The New England Journal of Medicine|date=2008-03-13|volume=358|issue=11|pages=1089–92|pmid=18337598|doi=10.1056/NEJMp0800809}}</ref>。 未感染HIV的肺結核患者中，有約5～10%日後發展為開放性肺結核； 相比之下，同時感染HIV的肺結核患者日後有30％發展為開放性肺結核<ref name=Pet2005/>。肺結核與擁擠環境、[[營養不良|營養不良]]相關，這些特性使其成為{{le|貧窮病|disease of proverty}}之一<ref name=Lancet11/>。 其他高風險因子則包含注射毒品、人口聚集場所居民及工作人員（如收容所及監獄）、醫療衛生較差區域、某些特定種族、與病患長期接觸的孩童，以及醫療照護人員等等<ref name=Griffith_1996>{{cite journal |vauthors=Griffith D, Kerr C | title=Tuberculosis: disease of the past, disease of the present | journal=Journal of Perianesthesia Nursing | volume=11 | issue=4 | pages=240–5 | year=1996 | pmid=8964016 | doi=10.1016/S1089-9472(96)80023-2 }}</ref>。慢性肺部疾病是另一種重要的危險因子。{{link-en|矽肺症|Silicosis}}提高了大約30倍的風險<ref name=":2" />。[[香煙|吸煙者]]相於沒有吸煙的族群，有大約兩倍罹患肺結核的風險<ref>{{cite journal|last=van Zyl Smit|first=RN|author2=Pai, M |author3=Yew, WW |author4=Leung, CC |author5=Zumla, A |author6=Bateman, ED |author7=Dheda, K |title=Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD| journal=European Respiratory Journal |date=January 2010|volume=35|issue=1|pages=27–33|pmid=20044459|quote=These analyses indicate that smokers are almost twice as likely to be infected with TB and to progress to active disease (RR of about 1.5 for latent TB infection (LTBI) and RR of ∼2.0 for TB disease). Smokers are also twice as likely to die from TB (RR of about 2.0 for TB mortality), but data are difficult to interpret because of heterogeneity in the results across studies.|doi=10.1183/09031936.00072909}}</ref>。另外還有一些疾病也會提高肺結核的風險，包含[[酗酒|酗酒]]、[[糖尿病|糖尿病]] (提高約3倍的患病機率) <ref>{{Cite journal|title=Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances|url=https://pubmed.ncbi.nlm.nih.gov/17638190|last=Restrepo|first=Blanca I.|date=2007-08-15|journal=Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America|issue=4|doi=10.1086/519939|volume=45|pages=436–438|issn=1537-6591|pmc=2900315|pmid=17638190}}</ref>。某些藥物也逐漸成為重要的風險因子，尤其是在[[已開發國家|已開發國家]]。例如[[皮質類固醇|皮質類固醇]] 和 {{link-en|Infliximab|Infliximab}} (一種抗αTNF的單株抗體)。{{link-en|遺傳易感性|Genetic susceptibility}} 也是危險因子之一，然而其重要性目前仍未確立<ref name="Lancet11" /><ref>{{cite journal|last=Möller|first=M|author2=Hoal, EG |title=Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis|journal=Tuberculosis |date=March 2010|volume=90|issue=2|pages=71–83|pmid=20206579|doi=10.1016/j.tube.2010.02.002}}</ref>。

==發病機制==
[[File:TB_poster.jpg|thumb]]

===傳染途徑===
肺結核不會經由無生命的東西傳染，必須要直接或間接吸入飛沫才會得病<ref>[http://www.chhw.mohw.gov.tw/chhw_mdr/main.php?index=hygiene_sub&bsid=&no=a00&pid=1 衛生福利部 彰化醫院 MDR-TB]</ref>。當患有開放性肺結核的患者咳嗽、打噴嚏、說話、唱歌或吐痰，患者會釋放出具有傳染性、直徑0.5至5.0µm([[微米|微米]])的懸浮粒子。每個噴嚏可釋放出高達40,000顆懸浮粒子<ref name=Cole_1998>{{cite journal |vauthors=Cole E, Cook C |title=Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies |url=https://archive.org/details/sim_american-journal-of-infection-control_1998-08_26_4/page/453 |journal=Am J Infect Control |volume=26 |issue=4 |pages=453–64 |year=1998 |pmid=9721404|doi = 10.1016/S0196-6553(98)70046-X}}</ref>。由於肺結核的感染劑量非常低(吸入少於十個細菌即有可能造成感染)，每一顆懸浮粒子都可能造成傳染<ref>{{cite journal |vauthors=Nicas M, Nazaroff WW, Hubbard A |title=Toward understanding the risk of secondary airborne infection: emission of respirable pathogens |journal=J Occup Environ Hyg |volume=2 |issue=3 |pages=143–54 |year=2005 |pmid=15764538|doi = 10.1080/15459620590918466}}</ref>。

結核菌必須包在飛沫（aerosol droplet）中才能達到感染的效果，當一個傳染性肺結核病患在吐痰、咳嗽或打噴嚏時，含有結核菌的痰有機會變成細小的飛沫飄浮到空氣中，飛沫的中心是結核菌，周圍是痰，當痰逐漸蒸發，飛沫直徑小到 5μm 以下時便可能直接進入正常人的肺泡，躲過宿主原有的呼吸道纖毛防衛機制（mucociliary system），直接與肺泡巨噬細胞接觸。如吸入的結核菌數量不多、毒性不強；宿主巨噬細胞殺死結核菌能力相對足夠的狀況下，並不會導致感染。但如果一切狀況不利於宿主，結核菌就有可能開始增殖<ref name=":0">{{Cite web|url=http://www.cdc.gov.tw/professional/info.aspx?treeid=89b930c89c1c71cf&nowtreeid=37e21e0a5dcdb27c&tid=AA8B780D65A0B152|title=結核病防治工作手冊-第二版( 2016-03-23)|accessdate=2016-05-01|author=台灣衛生福利部疾病管制署|date=2016-03-23|publisher=台灣衛生福利部疾病管制署|archive-url=https://web.archive.org/web/20160911040824/http://www.cdc.gov.tw/professional/info.aspx?treeid=89b930c89c1c71cf&nowtreeid=37e21e0a5dcdb27c&tid=AA8B780D65A0B152|archive-date=2016-09-11|dead-url=yes}}</ref>。與肺結核患者長期、頻繁或親密接觸者皆有非常高的感染風險，感染率約為22%<ref name=Ahmed_2011>{{cite journal |vauthors=Ahmed N, Hasnain S |title=Molecular epidemiology of tuberculosis in India: Moving forward with a systems biology approach |url=https://archive.org/details/sim_tuberculosis_2011-09_91_5/page/407 |journal=Tuberculosis |volume=91 |issue=5 |pages=407–3 |year=2011|pmid = 21514230|doi = 10.1016/j.tube.2011.03.006}}</ref>。未經治療的開放性肺結核患者每年會傳染10至15人(或更多)<ref name="WHO2012data"/>肺結核只由開放性患者傳染給其他人（也就是说所有「活動性」患者也具感染性），而潛伏結核感染患者與非開放性肺結核患者一般並不被認為具有感染性<ref name=Robbins/>。多個因素同時影響個體之間的傳染機率，其中包括病患噴出飛沫的懸浮粒子數量、通風情況、暴露於感染源的持續時間、結核分枝桿菌[[分型|菌株]]的[[病毒性|致病性]]，以及個體的免疫力等等<ref name=CDCcourse>{{cite web|publisher=[[Centers_for_Disease_Control_and_Prevention|Centers for Disease Control and Prevention]] (CDC), Division of Tuberculosis Elimination|url=http://www.cdc.gov/tb/education/corecurr/pdf/corecurr_all.pdf|title=Core Curriculum on Tuberculosis: What the Clinician Should Know|page=24|edition=5th|year=2011|accessdate=2017-01-27|archive-date=2012-05-19|archive-url=https://web.archive.org/web/20120519141115/http://www.cdc.gov/tb/education/corecurr/pdf/corecurr_all.pdf|dead-url=no}}</ref>。人與人間的傳染可以藉由隔離具有傳染性肺結核的患者和給予抗結核的藥物治療來避免。大約在兩個星期有效的治療後，沒有[[抗生素抗藥性|抗生素抗藥性]]之患者一般不會傳染給其他者<ref name="Ahmed_2011"/>。人被傳染後通常需要3至4周的時間，才會具有足夠傳染力去傳染別人<ref>{{cite web|url=http://www.mayoclinic.com/health/tuberculosis/DS00372/DSECTION=3|title=Causes of Tuberculosis|accessdate=2007-10-19|date=2006-12-21|publisher=[[Mayo_Clinic|Mayo Clinic]]|archive-date=2007-10-18|archive-url=https://web.archive.org/web/20071018051807/http://www.mayoclinic.com/health/tuberculosis/DS00372/DSECTION%3D3|dead-url=no}}</ref>。

===病因===
[[File:Tuberculous_epididymitis_Low_Power.jpg|thumb]]]]
大約90％的結核桿菌感染者是[[無症狀|無症狀]] 、潛伏的（也被稱為潛伏結核感染，LTBI)<ref name=Book90>{{cite book|last=Skolnik|first=Richard|title=Global health 101|year=2011|publisher=Jones & Bartlett Learning|location=Burlington, MA|isbn=978-0-7637-9751-5|pages=253|url=https://books.google.com/books?id=sBQRpj4uWmYC&pg=PA253|edition=2nd}}</ref>，結核病由結核感染期進展至臨床結核病期的時間差變異大，短則數週，長可達一生，受感染宿主終生危險期(lifetime risk)為10%。進展時間呈指數分布，約70—80%的臨床結核病在感染後5年內發生。停留於結核感染期者，無臨床症狀也不具感染性，稱為潛伏性結核感染<ref name="臨床微">吳俊忠、吳雪霞、周以正、周如文、胡文熙、洪貴香、孫培倫等十七人. 臨床微生物學：細菌與黴菌學 第七版.台北市: 五南圖書出版股份有限公司.2019年10月: 134.  ISBN 978-957-763-609-6</ref>， 只有10％的感染者的一生中某個時段會發展成開放性結核病。而HIV感染者中有潛伏結核感染的發展為開放性結核病的機率可增加至每年10％<ref name="Arch2009">{{cite book|last=editors|first=Arch G. Mainous III, Claire Pomeroy,|title=Management of antimicrobials in infectious diseases: impact of antibiotic resistance.|year=2009|publisher=Humana Press|location=Totowa, N.J.|isbn=978-1-60327-238-4|pages=74|url=https://books.google.com/books?id=hwVFAPLYznsC&pg=PA74|edition=2nd rev.}}</ref>。若未經有效治療，開放性結核病的死亡率可達66％<ref name=WHO2012data>{{cite web|url=http://www.who.int/mediacentre/factsheets/fs104/en/index.html|title=Tuberculosis Fact sheet N°104|publisher=[[World_Health_Organization|World Health Organization]]|date=November 2010|accessdate=2011-07-26|archive-date=2013-12-30|archive-url=https://web.archive.org/web/20131230232509/http://www.who.int/mediacentre/factsheets/fs104/en/index.html|dead-url=no}}</ref>。

肺結核感染始於結核桿菌感染[[肺泡|肺泡]]，結核桿菌可侵入肺泡並在其[[巨噬細胞|巨噬細胞]]的[[核內體|核內體]]中複製<ref name="Robbins" /><ref name="Houben">{{cite journal |vauthors=Houben E, Nguyen L, Pieters J | title=Interaction of pathogenic mycobacteria with the host immune system | journal=Curr Opin Microbiol | volume=9 | issue=1 | pages=76–85 | year=2006 | pmid=16406837 | doi=10.1016/j.mib.2005.12.014 }}</ref>。巨噬細胞辨認結核桿菌為異己並嘗試以[[吞噬作用|吞噬作用]]清除。在此過程中，結核桿菌被巨噬細胞包裹并暫時儲存於吞噬體中，即一種膜連型囊泡。之後吞噬體與溶酶體結合，形成吞噬溶酶體。在吞噬溶酶體中細胞嘗試使用[[活性氧類|活性氧類]]及酸來殺死細菌，但結核桿菌有一層蠟狀的厚層{{link-en|黴菌酸|mycolic acid}}構成的囊狀結構，以此保護其自身免於毒性物質的侵害。因此結核桿菌可以在巨噬細胞里複製并最終殺死巨噬細胞。

臨床結核病(clinical tuberculosis)中，一般感染後5年內發病者，為原發性結核病(primary tuberculosis)，超過5年者為次發性結核病(secondary tuberculosis)<ref name="臨床微"/>。原發性肺結核在肺部好發的部位稱為「{{link-en|肺结核原发病灶（Ghon氏病灶）|Ghon focus}}」，通常位於[[肺|下葉]]的上半部或是上葉的[[肺|下半部]]<ref name=Robbins/>。結核菌也可能透過血液循環而感染到肺部，通常會感染道肺部的頂部這被稱作「{{link-en|Simon氏病灶|Simon focus}}」<ref>{{cite book|last=Khan|title=Essence Of Paediatrics|year=2011|publisher=Elsevier India|isbn=978-81-312-2804-3|pages=401|url=https://books.google.com/books?id=gERCc6KTxwoC&pg=PA401}}</ref>。80%以上的結核菌會感染肺部形成肺結核<ref name="臨床微"/>，血液循環也可能把感染帶到身體其他遠端部位，例如週邊淋巴結、腎臟、腦部和骨骼，造成肺外結核<ref name=Robbins/><ref name=Herrmann_2005>{{cite journal |vauthors=Herrmann J, Lagrange P |title=Dendritic cells and ''Mycobacterium tuberculosis'': which is the Trojan horse? |journal=Pathol Biol (Paris) |volume=53 |issue=1 |pages=35–40 |year=2005|pmid = 15620608 |doi=10.1016/j.patbio.2004.01.004}}</ref>。全身所有部位都有機會被結核菌感染，但是[[心臟|心臟]]、[[骨骼肌|骨骼肌]]、[[胰臟|胰臟]]以及[[甲狀腺|甲狀腺]]較少受到侵犯，其機制至今未明<ref>{{cite journal |vauthors=Agarwal R, Malhotra P, Awasthi A, Kakkar N, Gupta D |pmc=1090580 |title=Tuberculous dilated cardiomyopathy: an under-recognized entity? |journal=BMC Infect Dis |volume=5 |issue=1 |page=29 |year=2005 |pmid=15857515 |doi=10.1186/1471-2334-5-29}}</ref>。肺外結核患者不一定會咳嗽，最明顯症狀則是感染處腫脹、疼痛<ref name="臨床微"/>。
[[File:Carswell-Tubercle.jpg|thumb]]

結核病被歸類為一種{{link-en|肉芽腫性|granuloma}}炎症。[[巨噬細胞|巨噬細胞]]、[[T細胞|T細胞]]、[[B細胞|B細胞]]以及[[纖維母細胞|纖維母細胞]]<!-- 及其他細胞 --> 聚集為[[肉芽腫|肉芽腫]]，且[[淋巴細胞|淋巴細胞]]會圍繞受感染的巨噬細胞。其他巨噬細胞會在肺泡囊融合為一個多核的細胞以攻擊受感染的巨噬細胞。肉芽腫的形成可以避免結核桿菌散播，也提供一個局部環境讓免疫系統的細胞之間交互作用<ref name=Grosset />。然而，最近的證據顯示結核桿菌利用肉芽腫避免被宿主免疫系統破壞。巨噬細胞和[[樹狀細胞|樹狀細胞]]在肉芽腫中無法發揮對淋巴球[[抗原呈現|呈現抗原]] 的功能，這即導致免疫反應被抑制<ref>{{Cite journal|title=IMMUNOLOGY OF TUBERCULOSIS|url=https://www.mjhid.org/index.php/mjhid/article/view/2014.027|last=Bozzano|first=Federica|last2=Marras|first2=Francesco|date=2014-04-07|journal=Mediterranean Journal of Hematology and Infectious Diseases|issue=1|doi=10.4084/mjhid.2014.027|volume=6|pages=e2014027|issn=2035-3006|pmc=PMC4010607|pmid=24804000|last3=De Maria|first3=Andrea}}</ref>。肉芽腫中的細菌可能休眠，造成潛伏感染。肉芽腫的另一個特色是會造成{{link-en|結節|Tubercle (anatomy)}}中心的不正常的細胞[[壞死|壞死]]。在肉眼觀察下，這樣的病灶會呈現質地軟類似白色乳酪的壞死，稱為{{link-en|乾酪性壞死|caseous necrosis}}<ref name="Grosset">{{cite journal |author=Grosset J |title=Mycobacterium tuberculosis in the Extracellular Compartment: an Underestimated Adversary |journal=Antimicrob Agents Chemother |volume=47 |issue=3 |pages=833–6 |year=2003|pmid = 12604509|doi = 10.1128/AAC.47.3.833-836.2003 |pmc=149338}}</ref>。

當結核菌從受感染的組織進入血流，它們可以在身體散佈，並在組織中形成許多細小的白色節結<ref>{{cite book|last=Crowley|first=Leonard V.|title=An introduction to human disease: pathology and pathophysiology correlations|year=2010|publisher=Jones and Bartlett|location=Sudbury, Mass.|isbn=978-0-7637-6591-0|pages=374|url=https://books.google.com/books?id=TEiuWP4z_QIC&pg=PA374|edition=8th}}</ref>。這種嚴重的結核病稱做{{le|粟粒狀結核|Milliary tuberculosis}}，最好發的族群是年幼孩童和[[人類免疫缺陷病毒|人類免疫缺陷病毒]]患者<ref>{{cite book|last=Anthony|first=Harries|title=TB/HIV a Clinical Manual.|year=2005|publisher=World Health Organization|location=Geneva|isbn=978-92-4-154634-8|pages=75|url=https://books.google.com/books?id=8dfhwKaCSxkC&pg=PA75|edition=2nd }}</ref>。罹患這種瀰漫型的結核病，即使經過治療也有很高的死亡率 (大約30%)<ref name="Gho2008" /><ref>{{cite journal|last=Jacob|first=JT |author2=Mehta, AK |author3=Leonard, MK|title=Acute forms of tuberculosis in adults|url=https://archive.org/details/sim_american-journal-of-medicine_2009-01_122_1/page/12|journal=The American Journal of Medicine|date=January 2009|volume=122|issue=1|pages=12–7|pmid=19114163|doi=10.1016/j.amjmed.2008.09.018}}</ref>。

在大多數的患者中，感染病程起起伏伏。組織的破壞和壞死通常以癒合和[[纖維化|纖維化]]作結。受侵犯的組織通常會被疤痕或填滿乾酪性壞死的空腔所取代。在開放性肺結核的時期，一些空腔與空氣行經的[[支氣管|支氣管]]相連，內含的物質就會被咳出來，也包含了結核菌的活體，於是透過這種方式傳播。適當的[[抗細菌藥|抗生素]]治療可以殺死細菌，並讓癒合得以進行。當痊癒時，受感染的區域最終會被疤痕組織取代<ref name="Grosset" />。

== 診斷 ==
[[File:TB_in_sputum.png|thumb]]中的[[結核菌|結核菌]]（經{{link-en|耐酸性染色|Ziehl-Neelsen stain}}呈紅色）]]
{{main|結核病診斷}}
診斷的方法可以依據臨床表現與X光，也可以參考[[結核菌素試驗|結核菌素試驗]]、組織病理切片、[[耐酸性染色|耐酸性染色]]、結核菌培養、MTB PCR。

===活動性結核病（開放性結核病）===
只依據臨床表現和症狀就要下活動性結核病的診斷並不容易<ref name=DiagP2011>{{cite journal|last=Bento|first=J |author2=Silva, AS |author3=Rodrigues, F |author4=Duarte, R|title=[Diagnostic tools in tuberculosis]|journal=[[Acta_Médica_Portuguesa|Acta Médica Portuguesa]]|date=Jan–Feb 2011|volume=24|issue=1|pages=145–54|pmid=21672452}}</ref>，如同在免疫低下的個案診斷這類疾病。當肺部症狀或{{link-en|全身癥狀|constitutional symptoms}}持續超過兩週時，結核病的診斷就應該被考慮。初步檢查典型包含了[[胸部X光|胸部X光]]、多套針對{{link-en|抗酸菌|Acid-fast}}的{{link-en|痰液培養|sputum culture}}<ref name="Clinic2009">{{cite journal|title=In the clinic. Tuberculosis|last=Escalante|first=P|date=2009-06-02|journal=Annals of Internal Medicine|issue=11|doi=10.7326/0003-4819-150-11-200906020-01006|volume=150|pages=ITC61–614; quiz ITV616|pmid=19487708}}</ref>。丙型干擾素檢驗與結核菌素皮膚測試在開發中國家有一點角色<ref>{{cite journal|last=Metcalfe|first=JZ |author2=Everett, CK |author3=Steingart, KR |author4=Cattamanchi, A |author5=Huang, L |author6=Hopewell, PC |author7=Pai, M|title=Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis|journal=The Journal of Infectious Diseases|date=2011-11-15|volume=204 Suppl 4|pages=S1120–9|pmid=21996694|doi=10.1093/infdis/jir410|pmc=3192542|issue=suppl_4}}</ref><ref name="Sester 100–11">{{cite journal|last=Sester|first=M |author2=Sotgiu, G |author3=Lange, C |author4=Giehl, C |author5=Girardi, E |author6=Migliori, GB |author7=Bossink, A |author8=Dheda, K |author9=Diel, R |author10=Dominguez, J |author11=Lipman, M |author12=Nemeth, J |author13=Ravn, P |author14=Winkler, S |author15=Huitric, E |author16=Sandgren, A |author17=Manissero, D |title=Interferon-γ release assays for the diag nosis of active tuberculosis: a systematic review and meta-analysis|journal=The European Respiratory Journal|date=January 2011|volume=37|issue=1|pages=100–11|pmid=20847080|doi=10.1183/09031936.00114810}}</ref>。丙型干擾素檢驗有些侷限，如同它在人類免疫缺陷病毒的角色一般<ref name="Sester 100–11"/><ref>{{cite journal|last=Chen|first=J|author2=Zhang, R |author3=Wang, J |author4=Liu, L |author5=Zheng, Y |author6=Shen, Y |author7=Qi, T |author8=Lu, H |title=Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis|journal=PLoS ONE|year=2011|volume=6|issue=11|pages=e26827|pmid=22069472|doi=10.1371/journal.pone.0026827|pmc=3206065|editor1-last=Vermund|editor1-first=Sten H}} {{open access}}</ref>。

要在檢體（痰、[[膿|膿]]或[[活體組織切片|活體組織切片]]）上確認到結核菌，才算是確定診斷患有結核病。但血液或痰液的細菌培養需二週到六週<ref>{{cite book|last=Diseases|first=Special Programme for Research & Training in Tropical|title=Diagnostics for tuberculosis : global demand and market potential.|year=2006|publisher=World Health Organization on behalf of the Special Programme for Research and Training in Tropical Diseases|location=Geneva|isbn=978-92-4-156330-7|pages=36|url=http://books.google.ca/books?id=CFPpcCef4yQC&pg=PA36|access-date=2015-01-20|archive-date=2014-11-10|archive-url=https://web.archive.org/web/20141110043735/http://books.google.ca/books?id=CFPpcCef4yQC&pg=PA36|dead-url=no}}</ref>，因此常會在確定有結核病前就開始治療<ref name=NICE2011>{{NICE|117|Tuberculosis|2011}}</ref>。因細菌學檢查後，檢體內有結核菌，此時病人具傳染性，為結核病防治的對象（稱為傳染性結核病或開放性結核病）。痰細菌學檢查一般採用塗片抗酸菌染色及結核菌培養二種方式，痰塗片可偵測出痰中細菌量大的病人；至於痰中細菌量小的病患，即痰塗片陰性者，可藉由痰培養發現細菌。研究顯示，同樣是培養陽性的病患，塗片陽性者的傳染性是塗片陰性者二倍以上。<ref name=":1">{{Cite web|url=http://www.cdc.gov.tw/diseaseinfo.aspx?treeid=8d54c504e820735b&nowtreeid=dec84a2f0c6fac5b&tid=BAB48CF8772C3B05|title=傳染病介紹 結核病|accessdate=2016-07-10|author=|date=|publisher=衛生福利部疾病管制署}}</ref>

{{link-en|核酸扩增试验|Nucleic acid amplification test}}及[[腺苷脱氨酶检测|腺苷脱氨酶检测]]檢驗可以提供結核病快速診斷<ref name=DiagP2011/>。不過因為這些檢驗方式鮮少改變病人的治療計畫，所以不是例行性的建議檢驗項目<ref name=NICE2011/>。檢驗血中的抗體因為[[靈敏度和特異度|靈敏度和特異度]]不出色，所以也不是建議的檢驗項目<ref>{{cite journal|last=Steingart|first=KR|coauthors=Flores, LL, Dendukuri, N, Schiller, I, Laal, S, Ramsay, A, Hopewell, PC, Pai, M|title=Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis|journal=PLoS medicine|date=August 2011|volume=8|issue=8|pages=e1001062|pmid=21857806|doi=10.1371/journal.pmed.1001062|pmc=3153457|editor1-last=Evans|editor1-first=Carlton}}</ref>。

===潛伏性結核病（非開放性結核病）===
{{main|潛伏性結核病}}
[[File:Mantoux_tuberculin_skin_test.jpg|thumb]]]]
痰液中找不到結核菌時，亦可由胸部X光檢查加上病人的臨床症狀，實驗室檢查之數據，作為肺結核的臨床診斷依據（稱非傳染性結核病或非開放性結核病）。<ref name=":1" />[[結核菌素試驗|結核菌素試驗]] 通常應用於篩檢結核病的高危險群<ref name=Clinic2009/>。先前接受過疫苗的人可能會有偽陽性的檢驗結果<ref name=Rothel_2005>{{cite journal|vauthors=Rothel J, Andersen P |title=Diagnosis of latent ''Mycobacterium tuberculosis'' infection: is the demise of the Mantoux test imminent?|journal=Expert Rev Anti Infect Ther |volume=3 |issue=6 |pages=981–93 |year=2005|pmid = 16307510|doi = 10.1586/14787210.3.6.981}}</ref>。罹患 [[結節病|結節病]]、[[霍奇金淋巴瘤|霍奇金淋巴瘤]]或是[[營養不良|營養不良]]的人，以及最需要注意的活動性結核病患者，可能會有偽陰性的檢驗結果<ref name=Robbins/>。抽血做{{link-en|丙型干擾素檢驗|Interferon gamma release assays}}（IGRAs）建議應用於結核菌素試驗陽性的個案<ref name="NICE2011"/>。丙型干擾素檢驗不會因為先前接種過疫苗或是大部分{{link-en|非結核性分枝桿菌|Nontuberculous mycobacteria}}而產生[[偽陽性|偽陽性]]<ref>{{cite journal|vauthors=Pai M, Zwerling A, Menzies D |title=Systematic Review: T-Cell–based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update |journal=Ann. Intern. Med. |volume=149 |issue=3 |pages=1–9 |year=2008 |pmid=18593687 |pmc=2951987|doi=10.7326/0003-4819-149-3-200808050-00241}}</ref>。然而可能會受到M. szulgai、M. marinum 以及 M. kansasii干擾<ref>{{cite book|last=Jindal|first=editor-in-chief SK|title=Textbook of Pulmonary and Critical Care Medicine|publisher=Jaypee Brothers Medical Publishers|location=New Delhi|isbn=978-93-5025-073-0|pages=544|url=https://books.google.com/books?id=rAT1bdnDakAC&pg=PA544|year=2011}}</ref>。丙型干擾素檢驗合併皮膚測試可以提高敏感度，然而單獨使用丙型干擾素檢驗的敏感度確比皮膚試驗還要低<ref>{{cite journal|last=Amicosante|first=M|author2=Ciccozzi, M |author3=Markova, R |title=Rational use of immunodiagnostic tools for tuberculosis infection: guidelines and cost effectiveness s tudies|journal=The new microbiologica|date=April 2010|volume=33|issue=2|pages=93–107|pmid=20518271}}</ref>。

== 預防 ==
肺結核的預防與控制須從嬰兒時期的疫苗施打，以及對活動性結核病患者的檢測及適當治療著手。[[世界衛生組織|世界衛生組織]]已藉著改善治療方法達到些許成效，並使感染人數有小幅度的下降<ref name="Lancet11" />。{{tsl|en|US Preventive Services Task Force|美國預防服務任務小組}}（USPSTF）建議對於可能罹患潛伏性結核病的高風險族群進行結核菌素試驗，或是全血丙型干擾素檢驗（{{lang|en|interferon-gamma release assays}}）<ref>{{cite journal|last1=Bibbins-Domingo|first1=Kirsten|last2=Grossman|first2=David C.|last3=Curry|first3=Susan J.|last4=Bauman|first4=Linda|last5=Davidson|first5=Karina W.|last6=Epling|first6=John W.|last7=García|first7=Francisco A.R.|last8=Herzstein|first8=Jessica|last9=Kemper|first9=Alex R.|last10=Krist|first10=Alex H.|last11=Kurth|first11=Ann E.|last12=Landefeld|first12=C. Seth|last13=Mangione|first13=Carol M.|last14=Phillips|first14=William R.|last15=Phipps|first15=Maureen G.|last16=Pignone|first16=Michael P.|title=Screening for Latent Tuberculosis Infection in Adults|journal=JAMA|date=2016-09-06|volume=316|issue=9|pages=962|doi=10.1001/jama.2016.11046}}</ref>。

===疫苗===
{{Main article|卡介苗}}
1920-21年，法国疫苗学家[[阿尔伯特·卡尔梅特|阿尔伯特·卡尔梅特]]和[[卡米尔·介兰|卡米尔·介兰]]研发出对抗结核病的[[卡介苗|卡介苗]]（BCG）<ref name=":3">{{Cite journal|title=Albert Calmette (1863-1933) and Camille Guérin (1872-1961): the C and G of BCG vaccine|url=https://pubmed.ncbi.nlm.nih.gov/17641786/|last=Hawgood|first=Barbara J.|date=2007-08|journal=Journal of Medical Biography|issue=3|doi=10.1258/j.jmb.2007.06-15|volume=15|pages=139–146|issn=0967-7720|pmid=17641786}}</ref>。截至2011年，對抗結核病的疫苗仍只有卡介苗一種<ref name=McS2011>{{cite journal|last=McShane|first=H|title=Tuberculosis vaccines: beyond bacille Calmette–Guérin|journal=Philosophical transactions of the Royal Society of London. Series B, Biological sciences|date=2011-10-12|volume=366|issue=1579|pages=2782–9|pmid=21893541|doi=10.1098/rstb.2011.0097|pmc=3146779}}</ref>。已接種卡介苗的孩童可降低20%的感染風險，感染後發病的風險也可降低近60%<ref>{{cite journal|last1=Roy|first1=A|last2=Eisenhut|first2=M|last3=Harris|first3=RJ|last4=Rodrigues|first4=LC|last5=Sridhar|first5=S|last6=Habermann|first6=S |last7=Snell|first7=L|last8=Mangtani|first8=P|last9=Adetifa|first9=I|last10=Lalvani|first10=A|last11=Abubakar|first11=I|title=Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis.|journal=BMJ (Clinical research ed.)|date=2014-08-05|volume=349|pages=g4643|pmid=25097193|doi=10.1136/bmj.g4643|pmc=4122754}}</ref>。

卡介苗是全世界被運用的最廣泛的疫苗，兒童[[疫苗接種|接種率]]超過九成。卡介苗的免疫作用在大約10年後會逐漸下降<ref name=Lancet11/>。結核病在加拿大、英國及美國不太普遍，因此卡介苗只會被使用在肺結核高風險的群眾上<ref>{{cite web|url=http://www.cdc.gov/tb/topic/vaccines/|title=Vaccine and Immunizations: TB Vaccine (BCG)|publisher=Centers for Disease Control and Prevention|year=2011|accessdate=2011-07-26|archive-url=https://web.archive.org/web/20111117140855/http://www.cdc.gov/tb/topic/vaccines/|archive-date=2011-11-17|dead-url=yes}}</ref><ref>{{cite web|title=BCG Vaccine Usage in Canada – Current and Historical|url=http://www.phac-aspc.gc.ca/tbpc-latb/bcgvac_1206-eng.php|work=Public Health Agency of Canada|accessdate=2011-12-30|date=September 2010|archive-url=https://web.archive.org/web/20120330042719/http://www.phac-aspc.gc.ca/tbpc-latb/bcgvac_1206-eng.php|archive-date=2012-03-30|dead-url=yes}}</ref><ref name=UK06>{{cite journal|last=Teo|first=SS|author2=Shingadia, DV |title=Does BCG have a role in tuberculosis control and prevention in the United Kingdom?|url=https://archive.org/details/sim_archives-of-disease-in-childhood_2006-06_91_6/page/529|journal=Archives of Disease in Childhood|date=June 2006|volume=91|issue=6|pages=529–31|pmid=16714729|pmc= 2082765|doi=10.1136/adc.2005.085043 }}</ref>。反對使用卡介苗的部分因素是因為它會造成[[結核菌素試驗|結核菌素試驗]]產生偽陽性的結果，減少此試驗的使用<ref name=UK06/>。目前有許多新的肺結核疫苗正在研發當中<ref name=Lancet11/>。2018年，M72/AS01<sub>E</sub>的第二期試驗顯示可以顯著降低開放性結核發生的風險<ref>{{Cite journal|title=Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis|author=|url=https://www.nejm.org/doi/full/10.1056/NEJMoa1803484|last=Van Der Meeren|first=Olivier|last2=Hatherill|first2=Mark|date=2018-10-25|journal=New England Journal of Medicine|issue=17|doi=10.1056/nejmoa1803484|others=|year=|volume=379|page=|pages=1621–1634|language=en|issn=0028-4793|pmc=6151253|pmid=30280651|last3=Nduba|first3=Videlis|last4=Wilkinson|first4=Robert J.|last5=Muyoyeta|first5=Monde|last6=Van Brakel|first6=Elana|last7=Ayles|first7=Helen M.|last8=Henostroza|first8=German|last9=Thienemann|first9=Friedrich}}</ref>。

===公共衛生===
世界衛生組織在1993年時宣布肺結核疫情進入「全球緊急狀態」（global health emergency）<ref name=Lancet11/>，在2006年{{le|終止結核伙伴聯盟|Stop TB Partnership}}發起了{{le|全球結核病防治計畫|Global Plan to Stop Tuberculosis}}，希望能在2006年到2015年之間救治1400萬條生命<ref>{{cite web|url=http://www.stoptb.org/global/plan/|title=The Global Plan to Stop TB|publisher=[[世界卫生组织|World Health Organization]]|year=2011|accessdate=2011-06-13|archive-date=2011-06-12|archive-url=https://web.archive.org/web/20110612030924/http://www.stoptb.org/global/plan/|dead-url=yes}}</ref>。然而，隨著HIV關聯的結核病患者增加，以及多重抗藥性菌株的影響，使這個目標在2015年時並未達成<ref name=Lancet11/>。[[美國胸腔協會|美國胸腔協會]]制定的{{le|結核病分級標準 |tuberculosis classification}}已被廣泛運用在公共衛生計畫當中<ref>{{cite book|last=Warrell|first=ed. by D. J. Weatherall ... [4. + 5. ed.] ed. by David A.|title=Sections 1 – 10.|year=2005|publisher=Oxford Univ. Press|location=Oxford [u.a.]|isbn=978-0-19-857014-1|pages=560|url=https://books.google.com/books?id=EhjX517cGVsC&pg=PA560|edition=4. ed., paperback.}}</ref>。

==治療==
[[File:TB_Culture.jpg|thumb]]在[[體外|體外]][[培養基|培養基]]上形成的[[菌落|菌落]]]]
[[File:Mycobacterium_tuberculosis_8438_lores.jpg|thumb]][[電子顯微鏡|電子顯微鏡]]下的[[結核桿菌|結核桿菌]]]]
{{Main article|結核病的治療}}結核病的治療通常使用[[抗细菌药|抗生素]]，但由於結核分枝桿菌細胞壁成分和構造較為特殊，藥物較難進入病原體中，因此難以發揮藥效<ref>{{cite journal |vauthors=Brennan PJ, Nikaido H |title=The envelope of mycobacteria |url=https://archive.org/details/sim_annual-review-of-biochemistry_1995_64/page/29 |journal=Annu. Rev. Biochem. |volume=64 |pages=29–63 |year=1995 |pmid=7574484 |doi=10.1146/annurev.bi.64.070195.000333}}</ref>。目前最常用的抗生素為[[异烟肼|异烟肼]]（Isoniazid）及[[利福平|利福平]]（Rifampin），且通常需服藥長達數月<ref name=CDCcourse/>。潛伏性結核病通常可給予單一抗生素治療，而活動性肺結核則最好同時合併使用多種抗生素治療，以減少結核菌產生[[抗生素抗藥性|抗藥性]]的風險。除活動性結核病患者外，潛伏性結核病患者也建議進行治療，以避免在未來惡化為活動性結核病<ref>{{Cite journal|title=Recent developments in treatment of latent tuberculosis infection|url=https://pubmed.ncbi.nlm.nih.gov/21441678|last=Menzies|first=Dick|last2=Al Jahdali|first2=Hamdan|date=2011-03|journal=The Indian Journal of Medical Research|volume=133|pages=257–266|issn=0971-5916|pmc=3103149|pmid=21441678|last3=Al Otaibi|first3=Badriah}}</ref>。結核病的治療需要長期不間斷的服藥，自行中斷服藥或忘記服藥容易導致治療失敗。因此[[世界衛生組織|世界衛生組織]]建議實施「{{le|都治計畫|Directly observed therapy}}」（DOTs），即由醫療照護人員親自定期送藥，監督患者確實服藥<ref>{{cite book |author1=Arch G. |author2=III Mainous |title=Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic Resistance |publisher=Humana Press |location=Totowa, N.J.|year=2010 |pages=69 |isbn=1-60327-238-0 |oclc= |url=https://books.google.com/books?id=hwVFAPLYznsC&pg=PA69}}</ref>。中華民國衛生福利部的資料顯示，實施都治計畫能有效降低治療失落率，與對照組比較起來也能明顯提升治療成功率<ref>{{Cite web|url=http://www.cdc.gov.tw/professional/|title=衛生福利部疾病管制署專業人士版|accessdate=2017-03-12|work=衛生福利部疾病管制署專業人士版|deadurl=yes|archiveurl=https://web.archive.org/web/20130502031859/http://www.cdc.gov.tw/professional|archivedate=2013-05-02}}</ref>。都治計畫的實施手段似乎對於治療成果有顯著影響<ref>{{Cite book|url=http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006594.pub3/abstract|title=Cochrane Database of Systematic Reviews|last=Liu|first=Qin|last2=Abba|first2=Katharine|last3=Alejandria|first3=Marissa M|last4=Sinclair|first4=David|last5=Balanag|first5=Vincent M|last6=Lansang|first6=Mary Ann D|date=2014-11-18|publisher=John Wiley & Sons, Ltd|year=|isbn=|location=|pages=|language=en|chapter=Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment|doi=10.1002/14651858.cd006594.pub3}}</ref>。然而在治癒率方面，計畫實施組與自主服藥組並沒有太大差異<ref>{{Cite journal|title=Directly observed therapy for treating tuberculosis|url=https://doi.wiley.com/10.1002/14651858.CD003343.pub4|last=Karumbi|first=Jamlick|last2=Garner|first2=Paul|date=2015-05-29|journal=Cochrane Database of Systematic Reviews|doi=10.1002/14651858.CD003343.pub4|editor-last=Cochrane Infectious Diseases Group|language=en|pmc=PMC4460720|pmid=26022367}}</ref>。

===首次發病===
截至2010年，肺結核首次發病的建議療法是六個月的抗生素綜合治療，首兩個月使用[[利福平|利福平]]、[[異煙肼|異煙肼]]（Isoniazid）、[[吡嗪酰胺|吡嗪酰胺]]（Pyrazinamide）及[[乙胺丁醇|乙胺丁醇]]（Ethambutol）；最後四個月只使用利福平和異煙肼。如果對異煙肼的抗藥性高，後四個月療程可用乙胺丁醇取代之<ref name=Lancet11/>。

===復發===
如果肺結核復發，在選擇治療方法前測試細菌對哪些抗生素有敏感性很重要。如果檢驗出細菌對{{tsl|en|Multidrug-resistant TB|多重抗藥性結核病|多種藥物有抗藥性}}（MDR-TB），建議使用最少四種有效的抗生素進行18到24個月的療程<ref name=Lancet11/>。

===抗藥性===
原發性抗藥性肺結核發生在受具抗藥性[[結核桿菌|結核桿菌]]感染的人中。帶有易受觸動的結核分枝桿菌的人可能在治療過程中因治療不足、沒有正確按醫囑服藥或藥物品質低劣而得到多發性肺結核<ref name=OBrien>{{cite journal |author=O'Brien R |title=Drug-resistant tuberculosis: etiology, management and prevention |journal=Semin Respir Infect |volume=9 |issue=2 |pages=104–12 |year=1994|pmid = 7973169}}</ref>。抗藥性肺結核在很多發展中國家是一個嚴重的公共衛生議題，因為這延長療程及需要較昂貴藥物。

多重抗藥性結核病（MDR-TB）的定義是結核菌同時對兩種最有效的第一線藥物利福平和異煙肼具抗藥性。[[广泛耐药结核|广泛耐药结核]]則是指同時對三種以上或六類第二線藥物具抗藥性<ref name="MMWR2006">{{cite journal |title=Emergence of ''Mycobacterium tuberculosis'' with extensive resistance to second-line drugs—worldwide, 2000–2004 |journal=MMWR Morb Mortal Wkly Rep |volume=55 |issue=11 |pages=301–5 |year=2006 |url=http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5511a2.htm |pmid=16557213 |author=Centers for Disease Control and Prevention (CDC) |access-date=2006-12-06 |archive-date=2020-01-12 |archive-url=https://web.archive.org/web/20200112192542/https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5511a2.htm |dead-url=no }}</ref>。{{tsl|en|Totally drug-resistant tuberculosis|完全抗藥性結核病}}是指對所有用作治療的藥物具抗藥性<ref name=TR2012>{{cite web|title=Totally Resistant TB: Earliest Cases in Italy|url=http://www.wired.com/wiredscience/2012/01/tdr-first-italy/|author=Maryn McKenna|date=2012-01-12|accessdate=2012-01-12|publisher=[[连线|Wired]]|archive-date=2012-01-14|archive-url=https://web.archive.org/web/20120114214156/http://www.wired.com/wiredscience/2012/01/tdr-first-italy/|dead-url=no}}</ref>。此類結核病於2003年在義大利首次發現<ref>{{cite journal|last1=Migliori|first1=G.B.|last2=De Iaco|first2=G.|last3=Besozzi|first3=G.|last4=Centis|first4=R.|last5=Cirillo|first5=D.M.|title=First tuberculosis cases in Italy resistant to all tested drugs|journal=Euro Surveillance|date=2007-05-17|volume=12|issue=5|page=E070517.1.|pmid=17868596}}</ref>，在伊朗和印度也有案例<ref name="EIU 2014"/><ref>{{cite journal|last1=Velayati|first1=A.A.|last2=Masjedi|first2=M.R.|last3=Farnia|first3=P.|last4=Tabarsi|first4=P.|last5=Ghanavi|first5=J.|last6=Ziazarifi |first6=A.H.|last7=Hoffner|first7=S.E.|title=Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran|url=https://archive.org/details/sim_chest_2009-08_136_2/page/420|journal=Chest|date=August 2009|volume=136|issue=2|pages=420–425|doi=10.1378/chest.08-2427|pmid=19349380}}</ref>，不過到2012年才有廣泛報告<ref name=TR2012/><ref>{{cite web|title=Totally Drug-Resistant TB: a WHO consultation on the diagnostic definition and treatment options|url=http://www.who.int/tb/challenges/xdr/Report_Meeting_totallydrugresistantTB_032012.pdf?ua=1|website=who.int|publisher=World Health Organization|accessdate=2016-03-25|archive-date=2016-10-21|archive-url=https://web.archive.org/web/20161021151601/http://www.who.int/tb/challenges/xdr/Report_Meeting_totallydrugresistantTB_032012.pdf?ua=1|dead-url=no}}</ref>。{{tsl|en|Bedaquiline|貝達喹啉}}（Bedaquiline）暫時受到認受作為治療多重抗藥性結核病的藥物<ref>{{cite web|title=Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis|url=http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6209a1.htm?s_cid=rr6209a1_x|accessdate=2017-03-12|archive-date=2014-01-04|archive-url=https://web.archive.org/web/20140104204359/http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6209a1.htm?s_cid=rr6209a1_x|dead-url=no}}</ref>。高劑量[[莫西沙星|莫西沙星]]配合其他抗結核病藥物也被證實可以縮短病程<ref>{{Cite journal|title=A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis|url=https://www.nejm.org/doi/10.1056/NEJMoa1811867|last=Nunn|first=Andrew J.|last2=Phillips|first2=Patrick P. J.|date=2019-03-13|journal=New England Journal of Medicine|doi=10.1056/NEJMoa1811867|language=en|last3=Meredith|first3=Sarah K.|last4=Chiang|first4=Chen-Yuan|last5=Conradie|first5=Francesca|last6=Dalai|first6=Doljinsuren|last7=Deun|first7=Armand van|last8=Dat|first8=Phan-Thuong|last9=Lan|first9=Ngoc}}</ref>。

在每十宗多重抗藥性結核病裡，就有一例是廣泛耐藥結核病。逾九成國家有廣泛耐藥結核病的病例<ref name="EIU 2014">{{cite journal|title=Ancient enemy, modern imperative – A time for greater action against tuberculosis|url=http://www.economistinsights.com/healthcare/analysis/ancient-enemy-modern-imperative|website=Economist Insights|publisher=The Economist Group|accessdate=2014-08-01|date=2014-06-30|author=Paul Kielstra|editor=Zoe Tabary|archive-date=2014-07-31|archive-url=https://web.archive.org/web/20140731145650/http://www.economistinsights.com/healthcare/analysis/ancient-enemy-modern-imperative|dead-url=no}}</ref>。

==預後==
[[File:Tuberculosis_world_map_-_DALY_-_WHO2004.svg|thumb]]圖（2004年）<ref>{{cite web |url=http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html |title=WHO Disease and injury country estimates |year=2004 |work=World Health Organization |accessdate=2009-11-11 |archive-date=2009-11-11 |archive-url=https://web.archive.org/web/20091111101009/http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html |dead-url=no }}</ref>
{{Col-begin}}
{{Col-break}}
{{legend|#b3b3b3|no data|size=60%}}
{{legend|#ffff65|≤10|size=60%}}
{{legend|#fff200|10–25|size=60%}}
{{legend|#ffdc00|25–50|size=60%}}
{{legend|#ffc600|50–75|size=60%}}
{{legend|#ffb000|75–100|size=60%}}
{{legend|#ff9a00|100–250|size=60%}}
{{Col-break}}
{{legend|#ff8400|250–500|size=60%}}
{{legend|#ff6e00|500–750|size=60%}}
{{legend|#ff5800|750–1000|size=60%}}
{{legend|#ff4200|1000–2000|size=60%}}
{{legend|#ff2c00|2000–3000|size=60%}}
{{legend|#cb0000|≥ 3000</small>|size=60%}}
{{col-end}}]]

當細菌突破免疫系統的防禦而開始增生時，疾病會由結核菌感染進展到症狀明顯的結核病。在原發型結核病 (佔 1-5% 的比例)，這種現象會在感染剛開始的時候很快的發生。然而多數人感染模式為{{tsl|en|Latent tuberculosis|潛伏結核感染}}，通常沒有明顯症狀<ref name=Robbins/>。在5-10%潛伏結合感染的案例中，這些休眠的細菌經常會在感染後數年的時間製造出活動的結核<ref name=Pet2005/>。

疾病再活化的機率會隨著免疫抑制增加，例如因為感染了人類免疫缺陷病毒。同時感染有結核菌和人類免疫缺陷病毒的患者，結核再活化得機率會上升到每年10%之多<ref name=Robbins/>。利用[[遺傳指紋分析|遺傳指紋分析]]鑑定結核菌的菌株的研究指出，「再度感染」在結核病復發的角色比先前的認知更重要<ref>{{cite journal |doi=10.1016/S1473-3099(03)00607-8 |title=Recurrence in tuberculosis: relapse or reinfection? |year=2003 |author=Lambert M |journal=Lancet Infect Dis |volume=3 |pmid=12726976 |issue=5 |name-list-format=vanc |display-authors=1 |last2=Hasker |first2=Epco |last3=Deun |first3=Armand Van |last4=Roberfroid |first4=Dominique |last5=Boelaert |first5=Marleen |last6=Van Der Stuyft |first6=Patrick |pages=282–7}}</ref>，估計在結核病盛行區域佔了疾病再活化的個案中的50%<ref>{{cite journal|last=Wang|first=JY |author2=Lee, LN |author3=Lai, HC |author4=Hsu, HL |author5=Liaw, YS |author6=Hsueh, PR |author7=Yang, PC|title=Prediction of the tuberculosis reinfection proportion from the local incidence|journal=The Journal of Infectious Diseases|date=2007-07-15|volume=196|issue=2|pages=281–8|pmid=17570116|doi=10.1086/518898}}</ref>。結核病的致死率在2008年大約為4%，相較於1995年的8%已有下降<ref name=Lancet11/>。

== 耐药变种 ==
由于病人漏服治疗药物，或在治疗周期完成前终止治疗而产生的结核病耐药变种对治疗药物有不同程度的[[抗药性|抗药性]]。对利福平（rifampicin）和异烟肼（isoniazid）等一线药物具抗药性的结核称作“[[多药抗药性结核|多药抗药性结核]]”（MDR-TB）。多药抗药性结核中，对全部[[喹诺酮|喹诺酮]]类药物以及至少对二线治疗结核药物中[[卡那霉素|卡那霉素]]（kanamycin）、[[卷曲霉素|卷曲霉素]]（capreomycin）和[[阿米卡霉素|阿米卡霉素]]之一具有抗药性的结核病称为[[广泛耐药结核|广泛耐药结核]]（XDR-TB）。

耐药结核具有死亡率高（MDR-TB死亡率与肺癌类似，XDR-TB更高出很多），传染性低的特点，通常只由普通结核病人治疗不当产生，只有在低免疫人群（如[[HIV|HIV]]普遍感染）中会出现人与人直接传播。

2012年1月，繼[[伊朗|伊朗]]後，在[[印度|印度]]也發現12例完全抗藥性肺結核病例，當中有10例發生於[[孟買|孟買]]<ref>{{cite news |url=http://www2.cna.com.tw/News/aHEL/201201080096.aspx |title=印發現完全抗藥性肺結核 |publisher=[[中央社|中央社]]即時新聞 |accessdate=2012-01-08 |date=2012-01-08 |language=zh-hant |archive-url=https://web.archive.org/web/20160215161317/http://www2.cna.com.tw/News/aHEL/201201080096.aspx |archive-date=2016-02-15 |dead-url=yes }}</ref>。
{{clear}}

== 歷史 ==

=== 工业革命前 ===
結核病是古老的疾病，至少可溯至[[新石器時代|新石器時代]]，在世界各地的歷史上都不乏有死於肺結核的名人，比如中国近代著名作家[[鲁迅|鲁迅]]、发明[[听诊器|听诊器]]的法國醫師[[雷奈克|雷奈克]]、演出[[電影|電影]]《[[亂世佳人|亂世佳人]]》的英國演員[[费雯·丽|費雯麗]]、日本作家[[石川啄木|石川啄木]]及現代俳句之父「俳聖」[[正岡子規|正岡子規]]，幕末時期新撰組的天才劍士，三段突刺的最後傳人[[沖田總司|沖田總司]]，以及台灣早期[[小說家|小說家]][[鍾理和|鍾理和]]，和發明數學公式，並對未來科學家研究黑洞有幫助的數學家[[斯里尼瓦瑟·拉馬努金|斯里尼瓦瑟·拉馬努金]]等等。歷代名醫對結核病都有深刻的認識。明代的[[李梃|李梃]]《[[医学入门|医学入门]]》指出肺痨六大主症为：“潮、汗、咳嗽，或见血，或遗精”。清朝人[[李用粹|李用粹]]《[[证治汇补|证治汇补]]》对结核病的描述：“痨瘵外候，睡中盗汗，午后发热，烦躁咳嗽，倦怠无力，饮食少进，痰涎带血，咯唾吐衄，肌肉消瘦”。

=== 工业革命及其后 ===
{{see also|第一次工业革命|第二次工业革命}}

18世纪、19世纪，结核病在欧洲成为[[流行病|流行病]]，其爆发呈现出季节性规律<ref name=":032">{{Cite web|title=History of Tuberculosis. Part 1 – Phthisis, consumption and the White Plague|url=https://jmvh.org/article/history-of-tuberculosis-part-1-phthisis-consumption-and-the-white-plague/|last=Frith|first=John|access-date=2021-02-26|website=Journal of Military and Veterans’ Health}}</ref><ref name=":52">{{Cite journal|title=Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051959/|last=Zürcher|first=Kathrin|last2=Zwahlen|first2=Marcel|date=2016-10-05|journal=PLoS ONE|issue=10|doi=10.1371/journal.pone.0162575|volume=11|issn=1932-6203|pmc=5051959|pmid=27706149|last3=Ballif|first3=Marie|last4=Rieder|first4=Hans L.|last5=Egger|first5=Matthias|last6=Fenner|first6=Lukas}}</ref>。工业革命期间，欧洲各国开始出现严重环境污染，工人生产、居住和公共卫生条件简陋，与结核病的流行紧密相关<ref name=":0323">{{Cite web|title=History of Tuberculosis. Part 1 – Phthisis, consumption and the White Plague|url=https://jmvh.org/article/history-of-tuberculosis-part-1-phthisis-consumption-and-the-white-plague/|last=Frith|first=John|access-date=2021-02-26|website=Journal of Military and Veterans’ Health}}</ref><ref name=":52" />。18世纪，西欧结核病的死亡率高达900人/每十万人口，北美地区也有相似死亡率<ref name=":032" /><ref name=":22">{{Cite journal|title=The history of tuberculosis|url=https://www.sciencedirect.com/science/article/pii/S095461110600401X|date=2006-11-01|journal=Respiratory Medicine|issue=11|doi=10.1016/j.rmed.2006.08.006|volume=100|pages=1862–1870|language=en|issn=0954-6111}}</ref><ref name=":32">{{Cite journal|title=The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432783/|last=Barberis|first=I.|last2=Bragazzi|first2=N.L.|date=March 2017|journal=Journal of Preventive Medicine and Hygiene|issue=1|volume=58|pages=E9–E12|issn=1121-2233|pmc=5432783|pmid=28515626|last3=Galluzzo|first3=L.|last4=Martini|first4=M.}}</ref> 。英国的流行性结核病在1750年左右达到高峰<ref name=":52" />。 19世纪，结核病大约杀死了四分之一的欧洲成年人口<ref>{{Cite web|title=The Next Pandemic - Tuberculosis: The Oldest Disease of Mankind Rising One More Time|url=https://www.bjmp.org/content/next-pandemic-tuberculosis-oldest-disease-mankind-rising-one-more-time|access-date=2021-02-26|website=British Journal of Medical Practitioners}}</ref>。在欧洲大陆西部，流行性结核病大概在19世纪上半叶到达高峰<ref name=":53">{{Cite journal|title=Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051959/|last=Zürcher|first=Kathrin|last2=Zwahlen|first2=Marcel|date=2016-10-05|journal=PLoS ONE|issue=10|doi=10.1371/journal.pone.0162575|volume=11|issn=1932-6203|pmc=5051959|pmid=27706149|last3=Ballif|first3=Marie|last4=Rieder|first4=Hans L.|last5=Egger|first5=Matthias|last6=Fenner|first6=Lukas}}</ref>。 此外，1851年至1910年间，[[英格兰|英格兰]]和[[威尔士|威尔士]]约有400万人死于结核病，超过1/3的15岁至34岁人口、一半的20岁至24岁人口死亡<ref name=":02">{{Cite web|title=History of Tuberculosis. Part 1 – Phthisis, consumption and the White Plague|url=https://jmvh.org/article/history-of-tuberculosis-part-1-phthisis-consumption-and-the-white-plague/|last=Frith|first=John|access-date=2021-02-26|website=Journal of Military and Veterans’ Health}}</ref>。 到了19世纪末，欧洲和北美地区约70–90%的城市人口携带[[結核桿菌|结核杆菌]]，而发病的人口中约80%死亡。但从同时间起，结核病在欧洲和美国的死亡率开始逐渐下降<ref>{{Cite web|title=Tuberculosis in Europe and North America, 1800-1922|url=https://curiosity.lib.harvard.edu/contagion/feature/tuberculosis-in-europe-and-north-america-1800-1922|access-date=2022-03-26|date=2020-03-26|work=Contagion - CURIOSity Digital Collections|language=en}}</ref>。

在结核病流行期间，人们曾称它为“年轻人的强盗（''the robber of youth''）”，因为青年人患病率和死亡率较高<ref name=":32" /><ref name=":02" />。其它的名字包括“白瘟疫（''the'' ''Great White Plague''）”以及“白死病（''the White Death''）”，因为患病者往往因[[贫血|贫血]]而脸色苍白<ref name=":32" /><ref name=":02" /><ref name=":4">{{Cite book|last=Daniel|first=Thomas M.|url=https://catalogue.nla.gov.au/Record/400512|title=Captain of death: the story of tuberculosis|date=1997|publisher=University of Rochester Press|isbn=978-1-878822-96-3|location=Rochester, NY, USA}}</ref>。此外，结核病也被许多人称为“所有这些死人的队长（Captain of All These Men of Death）”<ref name=":32" /><ref name=":02" /><ref name=":4" /><ref>{{Cite journal|title=Tuberculosis. Captain of all these men of death|url=https://pubmed.ncbi.nlm.nih.gov/7610235/|last=Rubin|first=S. A.|date=July 1995|journal=Radiologic Clinics of North America|issue=4|volume=33|pages=619–639|issn=0033-8389|pmid=7610235}}</ref>。

1882年，德國醫師[[罗伯特·科赫|罗伯特·科赫]]（{{lang|de|Robert Koch}}）首次發現[[结核杆菌|结核杆菌]]，他也因结核病的研究获得1905年[[诺贝尔生理学或医学奖|诺贝尔生理学或医学奖]]<ref>{{Cite web|title=The Nobel Prize in Physiology or Medicine 1905|url=https://www.nobelprize.org/prizes/medicine/1905/summary/|accessdate=2021-02-28|work=NobelPrize.org|language=en-US}}</ref>。1921年，[[阿尔贝·卡尔梅特|阿尔贝·卡尔梅特]]與[[卡米尔·介兰|卡米尔·介兰]]發明了[[卡介苗|卡介苗]]（BCG），用來預防肺結核，该疫苗已成为世界上最广泛接种的疫苗之一<ref name=":3" /><ref name=":5">{{Cite web|title=卡介苗|url=https://www.who.int/immunization/BCG_Chinese.pdf|accessdate=|author=|date=|format=|publisher=[[世界卫生组织|世界卫生组织]]|language=zh}}</ref>。1944年[[鏈黴素|鏈黴素]]（Streptomycin）發明<ref>{{cite web|author=范姜宇龍|url=http://www.nics.org.tw/old_nics/magazine/13/03/13-3-7.htm |language=zh |title=結核話說從頭 |publisher=台灣感染管制學會 |accessdate=2014-02-22}}</ref>，是為第一個有效的抗結核藥物。雖然新的抗結核藥物陸續被發展出來，然而結核病仍然是棘手的公共衛生問題。

==治療計畫==
===台灣都治(DOT)計畫===
消除結核第一期計劃從2016年至2035年發生率由每10萬人口46例降至10例。<ref>{{Cite web|url=http://www.cdc.gov.tw/professional/info.aspx?treeid=89b930c89c1c71cf&nowtreeid=37e21e0a5dcdb27c&tid=A835FF5D03B98AFA|title=結核病年度流病簡報( 2016-03-23)|accessdate=2016-05-01|author=衛生福利部疾病管制署|date=2016-03-23|publisher=衛生福利部疾病管制署|archive-url=https://web.archive.org/web/20160911050746/http://www.cdc.gov.tw/professional/info.aspx?treeid=89b930c89c1c71cf&nowtreeid=37e21e0a5dcdb27c&tid=A835FF5D03B98AFA|archive-date=2016-09-11|dead-url=yes}}</ref>結核病治療期程較長及藥物抗藥性等問題，直接觀察治療（Directly Observed Treatment Short-Course, DOTS；音譯為「都治」）是近年來世界衛生組織之策略。<ref name=":0" />DOTS計畫相當重要的目標是預防多重抗藥性細菌之產生，因此進一步針對多重抗藥性結核高盛行地區推出加強型都治計畫（DOTS-plus），以防止抗藥性結核問題繼續惡化<ref name="multiple">蘇維鈞. 肺結核大反撲之自保之道.台北市: 元氣齋出版社.2004年3月: 153. ISBN 978-986-759-611-6.</ref>。

結核病的DOTS包括五大要項的配套策略：政府對結核防治之政治承諾、正確的個案診斷模式、標準化之治療處方、充足的藥物供應、標準化之登記與通報系統。<ref name=":0" />

[[中華民國|中華民國]][[衛生福利部|衛生福利部]]為提升結核病照護成效下，進行的[[護理人員|護理人員]]監督計畫，執行階段：<ref>[http://www.cdc.gov.tw/professional/page.aspx?treeid=beac9c103df952c4&nowtreeid=24984562f1e74174 都治計畫] {{Wayback|url=http://www.cdc.gov.tw/professional/page.aspx?treeid=beac9c103df952c4&nowtreeid=24984562f1e74174 |date=20160819141842 }}[[衛生福利部|衛生福利部]][[疾病管制署|疾病管制署]]</ref><ref>[http://www.dryahoo.org.tw/次網頁/衛教走廊/流行病/結核病Q&A.htm 結核病 Q & A]</ref>
# 住院都治([[強制住院|強制住院]]治療)
# [[社區|社區]]都治：關懷員到社區間確認病人確實服用藥物
# [[長期照護|長期照護]]
# 回報案例
執行方式：<ref name=":0" />
# 關懷員送藥到點：由都治關懷員一事先約定好之服藥地點及時間，親自送藥到指定地點，親眼目睹病人服藥。
# 個案到點服藥：依病人服藥意願，病人自行至都治站，於關懷員或個案管理人員目視下服藥。
配套計畫：

為避免結核抗藥性繼續蔓延至無法控制，疾病管制局的都治計畫（如上述）以驗痰結果為主要指標。至於針對病患服藥的順從度不佳，健保局則推出「肺結核醫療給付改善試辦計畫」<ref name="multiple" />，鼓勵醫事機構提供結核病患整體性照護與個案管理的照護模式，為一套採取論質計酬的試辦計畫<ref>[https://ndltd.ncl.edu.tw/cgi-bin/gs32/gsweb.cgi/login?o=dnclcdr&s=id=%22091CMCH0528025%22.&searchmode=basic 論質計酬試辦計畫成效初探－以肺結核疾病為例] {{Wayback|url= https://ndltd.ncl.edu.tw/cgi-bin/gs32/gsweb.cgi/ccd=4SJmJz/login?jstimes=1&loadingjs=1&o=dwebmge&ssoauth=1&cache=1605833501834 |date=20201120085054 }}[[中華民國國家圖書館|國家圖書館]][[臺灣博碩士論文知識加值系統|臺灣博碩士論文知識加值系統]]</ref>。

==社會和文化==
[[世界衛生組織|世界衛生組織]]、[[比爾與美琳達·蓋茨基金會|比爾與美琳達·蓋茨基金會]]及美國政府在中低收入的國家進行一項計劃，用補貼的方式協助進行一項全新的速效诊断测试<ref name=PressRelease2012/><ref name=Xpert2011>{{cite journal|last=Lawn|first=SD|coauthors=Nicol, MP|title=Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance|journal=Future microbiology|date=September 2011|volume=6|issue=9|pages=1067–82|pmid=21958145|doi=10.2217/fmb.11.84|pmc=3252681}}</ref><ref>{{cite news |url=http://www.reuters.com/article/idUSTRE6B71RF20101208 |title=WHO says Cepheid rapid test will transform TB care |work=Reuters |date=2010-12-08 |accessdate=2014-02-22 |archive-date=2010-12-11 |archive-url=https://web.archive.org/web/20101211140847/http://www.reuters.com/article/idUSTRE6B71RF20101208 |dead-url=no }}</ref>。可以將成本由美金16.86元降至美金9.98元。此測試還可以確認結核病對[[利福平|利福平]]是否有抗藥性，若有，就有可能是多藥抗藥性結核，而且對於也有受愛滋病毒傳染的人也可以正確的檢測<ref name=PressRelease2012>{{cite web|title=Public-Private Partnership Announces Immediate 40 Percent Cost Reduction for Rapid TB Test|url=http://www.who.int/tb/features_archive/GeneXpert_press_release_final.pdf|work=World Health Organization|format=pdf|date=2012-08-06|accessdate=2014-02-22|archive-date=2013-10-29|archive-url=https://web.archive.org/web/20131029234310/http://www.who.int/tb/features_archive/GeneXpert_press_release_final.pdf|dead-url=no}}</ref><ref>{{cite web|title=The Stop TB Partnership, which operates through a secretariat hosted by the World Health Organization (WHO) in Geneva, Switzerland.|url=http://www.stoptb.org/wg/gli/assets/documents/map/XpertPublications.pdf|author=STOPTB|format=pdf|date=2013-04-05|accessdate=2014-02-22|archive-date=2014-01-24|archive-url=https://web.archive.org/web/20140124041952/http://www.stoptb.org/wg/gli/assets/documents/map/XpertPublications.pdf|dead-url=yes}}</ref>。不過在2011年時，有許多研究資源不足的國家仍只能用顯微鏡檢測痰液的方式來檢測<ref>{{cite journal|last=Lienhardt|first=C|coauthors=Espinal, M, Pai, M, Maher, D, Raviglione, MC|title=What research is needed to stop TB? Introducing the TB Research Movement|journal=PLoS medicine|date=November 2011|volume=8|issue=11|pages=e1001135|pmid=22140369|doi=10.1371/journal.pmed.1001135|pmc=3226454}}</ref>。

在2010年時印度的結核病患者最多，原因可能包括私人及公立醫療院所中的疾病控管能力不足<ref>{{cite journal|last=Mishra|first=G|title=Tuberculosis Prescription Practices In Private And Public Sector In India|journal=NJIRM|year=2013|volume=4|issue=2|pages=71–78|url=http://www.scopemed.org/?mno=36915|access-date=2014-02-22|archive-date=2013-05-10|archive-url=https://web.archive.org/web/20130510025039/http://www.scopemed.org/?mno=36915|dead-url=yes}}</ref>。像{{link-en|修订后的国家结核病控制计划|Revised National Tuberculosis Control Program}}（RNTCP）等計劃，有助於減少病人在進入醫療院所後得到結核的程度及比例<ref name="Bhargava">{{cite journal |author=Anurag Bhargava, Lancelot Pinto, Madhukar Pai |title=Mismanagement of tuberculosis in India: Causes, consequences, and the way forward |journal=Hypothesis |volume=9 |issue=1 |pages=e7 |year=2011 |url=http://www.hypothesisjournal.com/?p=989 |access-date=2014-02-22 |archive-url=https://web.archive.org/web/20200112192507/http://www.hypothesisjournal.com/?p=989 |archive-date=2020-01-12 |dead-url=yes }}</ref><ref>{{cite journal|last=Amdekar|first=Y|title=Changes in the management of tuberculosis|journal=Indian journal of pediatrics|date=July 2009|volume=76|issue=7|pages=739–42|pmid=19693453|doi=10.1007/s12098-009-0164-4}}</ref>。

由于监狱中恶劣而封闭的环境以及医疗卫生服务的缺乏，结核病在监狱中的发病率可达外界的100倍<ref>[https://www.icrc.org/chi/resources/documents/interview/tuberculosis-interview-240307.htm 监狱中的结核病向外传播]</ref>。针对监狱中的结核病患者，红十字国际委员会与世界卫生组织、当地政府以及医疗机构合作，通过提供资金和设备以及对监狱内外的医务人员进行培训，帮助被拘禁的患者获得及时治疗。在阿塞拜疆，红十字国际委员会与当地政府合作的治疗耐多药结核的试点项目使200多名患者获得治疗。<ref>[https://www.icrc.org/chi/resources/documents/interview/azerbaijan-interview-220310.htm 遏制结核病这个无法被禁锢于铁窗之内的杀手]</ref>而在吉尔吉斯斯坦两个监狱的治疗中，成功率已接近50%。<ref>[https://www.icrc.org/zh/document/tuberculosis-2015 在拘留场所抗击结核病]</ref>

== 世界紀念日 ==
=== [[世界结核病日|世界结核病日]] ===
聯合國、世界衛生組織（WHO）定於每年的3月24日為世界防治結核病日，以紀念1882年德國微生物學家羅伯特·科霍向一群德國柏林醫生發表他對結核病病原菌的發現。

==参考文献==
{{Reflist|2}}
==外部連結==
*[http://smallcollation.blogspot.com/2013/01/mycobacterium-tuberculosis.html 微生物免疫學-Mycobacterium tuberculosis(結核分枝桿菌)]
{{-}}

{{传染病}}
{{国家基本药物目录/抗微生物药|nocat}}
{{Authority control}}

[[Category:呼吸系统疾病|Category:呼吸系统疾病]]
[[Category:細菌性疾病|Category:細菌性疾病]]